| IMM_VITD_IFU_2025-03_V | IFU Access 25(OH) Vitamin D Total 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev F | Mở file ↗ |
| IMM_VITD-A98856_IFU_2025-03_A | IFU Access 25(OH) Vitamin D Total 03-2025 (A98856) | English | IFU | Access 2; DxI 800 | 03-2025 · Rev F | Mở file ↗ |
| IMM_VITD-B24838_IFU_2025-03_A | IFU Access 25(OH) Vitamin D Total 03-2025 (B24838) | English | IFU | Access 2; DxI 800 | 03-2025 · Rev F | Mở file ↗ |
| IMM_AFP_IFU_2025-03_A | IFU Access AFP 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev T | Mở file ↗ |
| IMM_AFP_IFU_2025-03_V | IFU Access AFP 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev T | Mở file ↗ |
| IMM_AMH_IFU_2025-03_A | IFU Access AMH 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev F | Mở file ↗ |
| IMM_AMH_IFU_2025-03_V | IFU Access AMH 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev F | Mở file ↗ |
| IMM_BNP_IFU_2025-03_A | IFU Access BNP 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev D | Mở file ↗ |
| IMM_BNP_IFU_2025-03_V | IFU Access BNP 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev D | Mở file ↗ |
| IMM_BR-MONITOR_IFU_2025-03_A | IFU Access BR Monitor (CA 15-3) 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_BR-MONITOR_IFU_2025-03_V | IFU Access BR Monitor (CA 15-3) 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_C-PEPTIDE_IFU_2025-03_A | IFU Access C-Peptide 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_C-PEPTIDE_IFU_2025-03_V | IFU Access C-Peptide 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_CEA_IFU_2025-05_A | IFU Access CEA 05-2025 | English | IFU | Access 2; DxI 800 | 05-2025 · Rev W | Mở file ↗ |
| IMM_CEA_IFU_2025-05_V | IFU Access CEA 05-2025 | Vietnamese | IFU | Access 2; DxI 800 | 05-2025 · Rev W | Mở file ↗ |
| IMM_CK-MB_IFU_2025-03_A | IFU Access CK-MB 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_CK-MB_IFU_2025-03_V | IFU Access CK-MB 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_CMV-IGG_IFU_2025-05_A | IFU Access CMV IgG 05-2025 | English | IFU | Access 2; DxI 800 | 05-2025 · Rev R | Mở file ↗ |
| IMM_CMV-IGG_IFU_2025-05_V | IFU Access CMV IgG 05-2025 | Vietnamese | IFU | Access 2; DxI 800 | 05-2025 · Rev R | Mở file ↗ |
| IMM_CMV-IGM_IFU_2025-05_A | IFU Access CMV IgM 05-2025 | English | IFU | Access 2; DxI 800 | 05-2025 · Rev P | Mở file ↗ |
| IMM_CMV-IGM_IFU_2025-05_V | IFU Access CMV IgM 05-2025 | Vietnamese | IFU | Access 2; DxI 800 | 05-2025 · Rev P | Mở file ↗ |
| IMM_CORTISOL_IFU_2025-04_A | IFU Access Cortisol 04-2025 | English | IFU | Access 2; DxI 800 | 04-2025 · Rev W | Mở file ↗ |
| IMM_CORTISOL_IFU_2025-04_V | IFU Access Cortisol 04-2025 | Vietnamese | IFU | Access 2; DxI 800 | 04-2025 · Rev W | Mở file ↗ |
| IMM_DHEA-S_IFU_2025-03_A | IFU Access DHEA-S 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_DHEA-S_IFU_2025-03_V | IFU Access DHEA-S 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_DIGOXIN_IFU_2025-03_A | IFU Access Digoxin 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev C | Mở file ↗ |
| IMM_DIGOXIN_IFU_2025-03_V | IFU Access Digoxin 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev C | Mở file ↗ |
| IMM_EPO_IFU_2025-03_A | IFU Access EPO 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_EPO_IFU_2025-03_V | IFU Access EPO 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_FERRITIN_IFU_2025-03_A | IFU Access Ferritin 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_FERRITIN-C64647E_IFU_2025-03_V | IFU Access Ferritin 03-2025 (C64647E) | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_FERRITIN-C64647E-HUYPD_IFU_2025-03_V | IFU Access Ferritin 03-2025 (C64647E-HUYPD) | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_FOLATE_IFU_2025-03_A | IFU Access Folate 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev F | Mở file ↗ |
| IMM_FOLATE_IFU_2025-03_V | IFU Access Folate 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev F | Mở file ↗ |
| IMM_FPSA_IFU_2025-03_A | IFU Access Free PSA 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev F | Mở file ↗ |
| IMM_FPSA_IFU_2025-03_V | IFU Access Free PSA 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev F | Mở file ↗ |
| IMM_FREET3_IFU_2025-05_A | IFU Access Free T3 05-2025 | English | IFU | Access 2; DxI 800 | 05-2025 · Rev H | Mở file ↗ |
| IMM_FREET3_IFU_2025-05_V | IFU Access Free T3 05-2025 | Vietnamese | IFU | Access 2; DxI 800 | 05-2025 · Rev H | Mở file ↗ |
| IMM_FREET4_IFU_2025-04_A | IFU Access Free T4 04-2025 – REF 33880 | English | IFU | Access 2; DxI 800 | 04-2025 · Rev T | Mở file ↗ |
| IMM_FREET4_IFU_2025-05_V | IFU Access Free T4 05-2025 | Vietnamese | IFU | Access 2; DxI 800 | 05-2025 · Rev F | Mở file ↗ |
| IMM_FREET4_IFU_2024-08_A | IFU Access Free T4 08-2024 – REF C76421 | English | IFU | Access 2; DxI 800 | 08-2024 · Rev B | Mở file ↗ |
| IMM_FSH_IFU_2025-03_A | IFU Access FSH 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_FSH_IFU_2025-03_V | IFU Access FSH 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_GI-MONITOR_IFU_2025-03_A | IFU Access GI Monitor (CA 19-9) 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev F | Mở file ↗ |
| IMM_GI-MONITOR_IFU_2025-03_V | IFU Access GI Monitor (CA 19-9) 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev F | Mở file ↗ |
| IMM_HAV-AB_IFU_2025-05_A | IFU Access HAV Ab 05-2025 | English | IFU | Access 2; DxI 800 | 05-2025 · Rev P | Mở file ↗ |
| IMM_HAV-AB_IFU_2025-05_V | IFU Access HAV Ab 05-2025 | Vietnamese | IFU | Access 2; DxI 800 | 05-2025 · Rev P | Mở file ↗ |
| IMM_HAV-IGM_IFU_2025-05_A | IFU Access HAV IgM 05-2025 | English | IFU | Access 2; DxI 800 | 05-2025 · Rev R | Mở file ↗ |
| IMM_HAV-IGM_IFU_2025-05_V | IFU Access HAV IgM 05-2025 | Vietnamese | IFU | Access 2; DxI 800 | 05-2025 · Rev R | Mở file ↗ |
| IMM_HBC-AB_IFU_2025-05_A | IFU Access HBc Ab 05-2025 | English | IFU | Access 2; DxI 800 | 05-2025 · Rev U | Mở file ↗ |
| IMM_HBC-AB_IFU_2025-05_V | IFU Access HBc Ab 05-2025 | Vietnamese | IFU | Access 2; DxI 800 | 05-2025 · Rev U | Mở file ↗ |
| IMM_HBC-IGM_IFU_2025-05_A | IFU Access HBc IgM 05-2025 | English | IFU | Access 2; DxI 800 | 05-2025 · Rev U | Mở file ↗ |
| IMM_HBC-IGM_IFU_2025-05_V | IFU Access HBc IgM 05-2025 | Vietnamese | IFU | Access 2; DxI 800 | 05-2025 · Rev U | Mở file ↗ |
| IMM_HBS-AB_IFU_2025-05_A | IFU Access HBs Ab 05-2025 | English | IFU | Access 2; DxI 800 | 05-2025 · Rev U | Mở file ↗ |
| IMM_HBS-AB_IFU_2025-05_V | IFU Access HBs Ab 05-2025 | Vietnamese | IFU | Access 2; DxI 800 | 05-2025 · Rev U | Mở file ↗ |
| IMM_HBSAG_IFU_2025-05_A | IFU Access HBsAg 05-2025 | English | IFU | Access 2; DxI 800 | 05-2025 · Rev T | Mở file ↗ |
| IMM_HBSAG_IFU_2025-05_V | IFU Access HBsAg 05-2025 | Vietnamese | IFU | Access 2; DxI 800 | 05-2025 · Rev T | Mở file ↗ |
| IMM_HCV-AB-V3_IFU_2023-04_A | IFU Access HCV Ab V3 04-2023 | English | IFU | Access 2; DxI 800 | 04-2023 · Rev B | Mở file ↗ |
| IMM_HCV-AB-V3_IFU_2023-04_V | IFU Access HCV Ab V3 04-2023 | Vietnamese | IFU | Access 2; DxI 800 | 04-2023 · Rev B | Mở file ↗ |
| IMM_HGH_IFU_2024-08_A | IFU Access hGH 08-2024 | English | IFU | Access 2; DxI 800 | 08-2024 · Rev N | Mở file ↗ |
| IMM_HGH_IFU_2024-08_V | IFU Access hGH 08-2024 | Vietnamese | IFU | Access 2; DxI 800 | 08-2024 · Rev D | Mở file ↗ |
| IMM_HIV-COMBO_IFU_2020-10_A | IFU Access HIV combo 10-2020 | English | IFU | Access 2; DxI 800 | 10-2020 · Rev F | Mở file ↗ |
| IMM_HIV-COMBO-V2_IFU_2021-02_A | IFU Access HIV combo V2 02-2021 | English | IFU | Access 2; DxI 800 | 02-2021 · Rev A | Mở file ↗ |
| IMM_HIV-COMBO-V2_IFU_2021-02_V | IFU Access HIV combo V2 02-2021 | Vietnamese | IFU | Access 2; DxI 800 | 02-2021 · Rev A | Mở file ↗ |
| IMM_HSTNI_IFU_2025-03_A | IFU Access hsTnI 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev D | Mở file ↗ |
| IMM_HSTNI_IFU_2025-03_V | IFU Access hsTnI 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev D | Mở file ↗ |
| IMM_IL-6_IFU_2025-03_A | IFU Access IL-6 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev C | Mở file ↗ |
| IMM_IL-6_IFU_2025-03_V | IFU Access IL-6 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_INHIBIN-A_IFU_2025-03_A | IFU Access Inhibin A 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev R | Mở file ↗ |
| IMM_INHIBIN-A_IFU_2025-03_V | IFU Access Inhibin A 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev R | Mở file ↗ |
| IMM_INSULIN_IFU_2025-03_A | IFU Access Insulin 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev P | Mở file ↗ |
| IMM_INSULIN_IFU_2025-03_V | IFU Access Insulin 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_IPTH_IFU_2025-03_A | IFU Access Intact PTH 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev D | Mở file ↗ |
| IMM_IPTH_IFU_2025-03_V | IFU Access Intact PTH 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev D | Mở file ↗ |
| IMM_IF-AB_IFU_2025-03_A | IFU Access Intrinsic Factor Ab 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_IF-AB_IFU_2025-03_V | IFU Access Intrinsic Factor Ab 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_LH_IFU_2025-03_A | IFU Access LH 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev R | Mở file ↗ |
| IMM_LH_IFU_2025-03_V | IFU Access LH 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_MYOGLOBIN_IFU_2025-03_A | IFU Access Myoglobin 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_MYOGLOBIN_IFU_2025-03_V | IFU Access Myoglobin 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_OSTASE_IFU_2025-03_A | IFU Access Ostase 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_OSTASE_IFU_2025-03_V | IFU Access Ostase 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_OV-MONITOR_IFU_2025-03_A | IFU Access OV Monitor (CA 125) 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_OV-MONITOR_IFU_2025-03_V | IFU Access OV Monitor (CA 125) 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_P2PSA_IFU_2025-04_A | IFU Access p2PSA 04-2025 | English | IFU | Access 2; DxI 800 | 04-2025 · Rev F | Mở file ↗ |
| IMM_P2PSA_IFU_2025-04_V | IFU Access p2PSA 04-2025 | Vietnamese | IFU | Access 2; DxI 800 | 04-2025 · Rev F | Mở file ↗ |
| IMM_PAPP-A_IFU_2025-04_A | IFU Access PAPP-A 04-2025 | English | IFU | Access 2; DxI 800 | 04-2025 · Rev F | Mở file ↗ |
| IMM_PAPP-A_IFU_2025-04_V | IFU Access PAPP-A 04-2025 | Vietnamese | IFU | Access 2; DxI 800 | 04-2025 · Rev F | Mở file ↗ |
| IMM_PCT_IFU_2025-03_A | IFU Access PCT 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev F | Mở file ↗ |
| IMM_PROGESTERONE_IFU_2025-03_A | IFU Access Progesterone 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev D | Mở file ↗ |
| IMM_PROGESTERONE_IFU_2025-03_V | IFU Access Progesterone 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev D | Mở file ↗ |
| IMM_PROLACTIN_IFU_2025-03_A | IFU Access Prolactin 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_PROLACTIN_IFU_2025-03_V | IFU Access Prolactin 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_PSA_IFU_2025-03_A | IFU Access PSA 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev F | Mở file ↗ |
| IMM_PSA_IFU_2025-03_V | IFU Access PSA 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev F | Mở file ↗ |
| IMM_RUBELLA-IGG_IFU_2025-05_A | IFU Access Rubella IgG 05-2025 | English | IFU | Access 2; DxI 800 | 05-2025 · Rev T | Mở file ↗ |
| IMM_RUBELLA-IGG_IFU_2025-05_V | IFU Access Rubella IgG 05-2025 | Vietnamese | IFU | Access 2; DxI 800 | 05-2025 · Rev T | Mở file ↗ |
| IMM_RUBELLA-IGM_IFU_2025-05_A | IFU Access Rubella IgM 05-2025 | English | IFU | Access 2; DxI 800 | 05-2025 · Rev V | Mở file ↗ |
| IMM_RUBELLA-IGM_IFU_2025-05_V | IFU Access Rubella IgM 05-2025 | Vietnamese | IFU | Access 2; DxI 800 | 05-2025 · Rev V | Mở file ↗ |
| IMM_SARS-COV-2-IGG_IFU_2024-09_A | IFU Access SARS-CoV-2 IgG 09-2024 | English | IFU | Access 2; DxI 800 | 09-2024 · Rev J | Mở file ↗ |
| IMM_SARS-COV-2-IGG-II_IFU_2024-09_V | IFU Access SARS-CoV-2 IgG II 09-2024 | Vietnamese | IFU | Access 2; DxI 800 | 09-2024 · Rev E | Mở file ↗ |
| IMM_SARS-COV-2-IGM_IFU_2024-08_A | IFU Access SARS-CoV-2 IgM 08-2024 | English | IFU | Access 2; DxI 800 | 08-2024 · Rev D | Mở file ↗ |
| IMM_SARS-COV-2-IGM_IFU_2024-08_V | IFU Access SARS-CoV-2 IgM 08-2024 | Vietnamese | IFU | Access 2; DxI 800 | 08-2024 · Rev D | Mở file ↗ |
| IMM_SENSITIVE-ESTRADIOL_IFU_2025-03_A | IFU Access Sensitive Estradiol 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev B | Mở file ↗ |
| IMM_SENSITIVE-ESTRADIOL_IFU_2025-03_V | IFU Access Sensitive Estradiol 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_SHBG_IFU_2025-03_A | IFU Access SHBG 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev U | Mở file ↗ |
| IMM_SHBG_IFU_2025-03_V | IFU Access SHBG 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_STFR_IFU_2025-03_A | IFU Access sTfR 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_STFR_IFU_2025-03_V | IFU Access sTfR 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_TESTOSTERONE_IFU_2025-03_A | IFU Access Testosterone 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_TESTOSTERONE_IFU_2025-03_V | IFU Access Testosterone 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_TG_IFU_2025-03_A | IFU Access Thyroglobulin 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_TG_IFU_2025-03_V | IFU Access Thyroglobulin 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_TGAB-II_IFU_2025-02_A | IFU Access Thyroglobulin Antibody II 02-2025 – REF C86552 | English | IFU | Access 2; DxI 800 | 02-2025 · Rev E | Mở file ↗ |
| IMM_TGAB-II_IFU_2025-03_V | IFU Access Thyroglobulin Antibody II 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev D | Mở file ↗ |
| IMM_TGAB-II_IFU_2025-03_A | IFU Access Thyroglobulin Antibody II 03-2025 – REF A32898 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev D | Mở file ↗ |
| IMM_TOTALT3_IFU_2025-03_A | IFU Access Total T3 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_TOTALT3_IFU_2025-03_V | IFU Access Total T3 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_TOTALT4_IFU_2025-03_A | IFU Access Total T4 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_TOTALT4_IFU_2025-03_V | IFU Access Total T4 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_TOTAL-BHCG_IFU_2025-03_A | IFU Access Total βhCG (5th IS) 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev N | Mở file ↗ |
| IMM_TOTAL-BHCG_IFU_2025-03_V | IFU Access Total βhCG (5th IS) 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev N | Mở file ↗ |
| IMM_TOXO-IGG_IFU_2025-05_A | IFU Access Toxo IgG 05-2025 | English | IFU | Access 2; DxI 800 | 05-2025 · Rev V | Mở file ↗ |
| IMM_TOXO-IGG_IFU_2025-05_V | IFU Access Toxo IgG 05-2025 | Vietnamese | IFU | Access 2; DxI 800 | 05-2025 · Rev V | Mở file ↗ |
| IMM_TOXO-IGM-II_IFU_2025-05_A | IFU Access Toxo IgM II 05-2025 | English | IFU | Access 2; DxI 800 | 05-2025 · Rev R | Mở file ↗ |
| IMM_TOXO-IGM-II_IFU_2025-05_V | IFU Access Toxo IgM II 05-2025 | Vietnamese | IFU | Access 2; DxI 800 | 05-2025 · Rev R | Mở file ↗ |
| IMM_TPO-AB_IFU_2025-05_A | IFU Access TPO Antibody 05-2025 | English | IFU | Access 2; DxI 800 | 05-2025 · Rev H | Mở file ↗ |
| IMM_TPO-AB_IFU_2025-05_V | IFU Access TPO Antibody 05-2025 | Vietnamese | IFU | Access 2; DxI 800 | 05-2025 · Rev H | Mở file ↗ |
| IMM_TSH-3RDIS_IFU_2025-03_A | IFU Access TSH (3rd IS) 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_TSH-3RDIS_IFU_2025-03_V | IFU Access TSH (3rd IS) 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev E | Mở file ↗ |
| IMM_UE3_IFU_2025-03_A | IFU Access Unconjugated Estriol 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev P | Mở file ↗ |
| IMM_UE3_IFU_2025-03_V | IFU Access Unconjugated Estriol 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev P | Mở file ↗ |
| IMM_VITB12_IFU_2025-03_A | IFU Access Vitamin B12 03-2025 | English | IFU | Access 2; DxI 800 | 03-2025 · Rev F | Mở file ↗ |
| IMM_VITB12_IFU_2025-03_V | IFU Access Vitamin B12 03-2025 | Vietnamese | IFU | Access 2; DxI 800 | 03-2025 · Rev F | Mở file ↗ |